The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Advances Day 2019 | EBMT CMWP data at ASH: MPN-U and second transplant
Donal McLornan, MB BCh, MRCP, PhD, FRCPath, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, discusses upcoming work on unclassifiable myeloproliferative neoplasms (MPNs) at the American Society of Hematology (ASH) Annual Meeting and Exposition 2019. This is a retrospective study by the European Society for Blood and Marrow Transplantation (EBMT) Chronic Malignancies Working Party on the outcome of allo-HSCT in MPNs-unclassifiable.This interview took place at the MPN Advances Day 2019 in London, UK.
